Internal Medicine, Pulmonary Disease · Hendersonville, TN
NPI
1346288966
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
102 Wessington Pl
Hendersonville, TN, 37075
Phone (615) 822-2214
Groups this clinician bills Medicare through
Medicare paid, 2024
$180K
2,065 services
Medicare patients, 2024
702
Average age 74
Drug cost, 2024
$4.4M
8,897 prescriptions
Company payments, 2025
$2,076
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Clyde O Southwell was code 99214 (office e&m - established), 695 times for 423 patients. In total Clyde O Southwell billed 2,065 services in 32 codes, and Medicare paid $180K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-01-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 695 | 423 | $86.89 | $60K |
| 99204 Office E&M - New | Office | 269 | 269 | $104.16 | $28K |
| 94729 Pulmonary Function Testing | Office | 147 | 144 | $37.42 | $5,501 |
| 94060 Pulmonary Function Testing | Office | 147 | 144 | $25.62 | $3,766 |
| 99232 Hospital E&M - Subsequent | Facility | 132 | 62 | $57.31 | $7,565 |
| 71046 X-ray - Chest | Office | 114 | 99 | $15.64 | $1,783 |
| 99223 Hospital E&M - Initial | Facility | 96 | 89 | $123.03 | $12K |
| 95810 Sleep Study | Office | 74 | 72 | $435.27 | $32K |
| 94618 Pulmonary Function Testing | Office | 54 | 51 | $23.44 | $1,266 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 49 | 13 | $0.09 | $4.46 |
| 95811 Sleep Study | Office | 44 | 43 | $445.82 | $20K |
| 94060 Pulmonary Function Testing | Facility | 24 | 24 | $7.51 | $180 |
| 94729 Pulmonary Function Testing | Facility | 24 | 24 | $6.50 | $156 |
| 95810 Sleep Study | Facility | 23 | 23 | $79.28 | $1,823 |
| 94010 Pulmonary Function Testing | Office | 23 | 23 | $18.38 | $423 |
By year: 2022 $200K for 2,430 services; 2023 $159K for 1,948 services; 2024 $180K for 2,065 services.
Lab tests billed to Medicare, 2023
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 13 | 13 | $8.40 | $109 |
Medicare prescription drug claims, 2024
In 2024, the drug Clyde O Southwell prescribed most often to Medicare patients was Albuterol Sulfate Hfa (Albuterol Sulfate), with 1,240 prescriptions and refills. In total Clyde O Southwell wrote 8,897 Medicare prescriptions that cost $4.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 1,240 | 2,155 | 554 | $53K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 1,036 | 1,778 | 336 | $1.1M |
| Fluticasone Propionate Generic | 836 | 1,740 | 464 | $13K |
| Azelastine Hcl Generic | 797 | 1,496 | 461 | $24K |
| Montelukast Sodium Generic | 778 | 1,888 | 307 | $9,805 |
| Azithromycin Generic | 345 | 450 | 164 | $3,787 |
| Spiriva Respimat Tiotropium Bromide | 313 | 577 | 114 | $294K |
| Breo Ellipta Fluticasone/Vilanterol | 288 | 453 | 93 | $174K |
| Varenicline Tartrate Generic | 261 | 298 | 117 | $47K |
| Prednisone Generic | 246 | 248 | 185 | $791 |
| Roflumilast Generic | 222 | 369 | 64 | $26K |
| Stiolto Respimat Tiotropium Br/Olodaterol Hcl | 212 | 342 | 71 | $161K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 205 | 368 | 86 | $35K |
| Breztri Aerosphere Budesonide/Glycopyr/Formoterol | 181 | 276 | 66 | $172K |
| Bupropion Xl Bupropion Hcl | 178 | 277 | 76 | $2,372 |
Brand drugs: 3,619 claims; generic drugs: 5,278 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Clyde O Southwell $2,076 ($2,076 in general payments such as food, travel and fees) from 18 companies. The largest payer was GlaxoSmithKline, LLC. with $489.
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. GSK | 27 | $489 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $310 |
| Insmed, Inc. INSM | 14 | $273 |
| Grifols USA, LLC | 7 | $172 |
| Verona Pharma, Inc. VRNA | 9 | $167 |
| Regeneron Healthcare Solutions, Inc. REGN | 6 | $145 |
| Viatris Specialty LLC | 6 | $117 |
| Genzyme Corporation SNY | 5 | $115 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $103 |
| Amgen Inc. AMGN | 2 | $46.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.